Inconsistent relationship between depth of sedation and intensive care outcome: systematic review and meta-analysis by Aitken, Leanne M. et al.
1 
 
Title:  Inconsistent relationship between depth of sedation and intensive care outcome: 
systematic review and meta-analysis 
Authors:  
Leanne M Aitken, PhD, Professor of Critical Care, School of Health Sciences, City, 
University of London, London, UK and School of Nursing and Midwifery, Griffith 
University, Brisbane, Australia. ORCID: 0000-0001-5722-9090 
Leanne.aitken.1@city.ac.uk Phone: +44 (0) 20 7040 5968 
Kalliopi Kydonaki, PhD, Lecturer, School of Health and Social Care, Edinburgh Napier 
University, Edinburgh, UK. ORCHID: 0000-0003-0607-7618 
C.Kydonaki@napier.ac.uk 
Bronagh Blackwood, PhD, Professor in Critical Care, Wellcome-Wolfson Institute for 
Experimental Medicine, Queen’s University Belfast, Belfast, Northern Ireland, UK. 
b.blackwood@qub.ac.uk 
Laurence G Trahair, PhD, Adelaide Medical School, The University of Adelaide, Adelaide, 
Australia, ORCID: 0000-0002-3479-8490 
trahair@internode.on.net 
Edward Purssell, PhD, Senior Lecturer, School of Health Sciences, City, University of 
London, London, UK 
Edward.Purssell@city.ac.uk 
Mandeep Sekhon, PhD, Department of Population Health Sciences, School of Population 
Health & Environmental Sciences, Faculty of Life Sciences and Medicine, King’s College 
London, London, UK 
mandeep.sekhon@kcl.ac.uk 
Timothy Simon Walsh, MD, Department of Anaesthesia, Critical Care & Pain Medicine and 




Corresponding Author: Leanne M Aitken, Professor of Critical Care, School of Health 
Sciences, City, University of London, Northampton Square, London, EC1V 0HB, UK  
Leanne.aitken.1@city.ac.uk Phone: +44 (0) 20 7040 5968 
Authors’ contributions to manuscript: Review concept and design – LMA, KK, BB, TSW; Study 
identification, critical appraisal and data extraction – LMA, KK, BB, LGT, MS; Statistical analysis – 
EP; Interpretation of analysis – all authors; drafting of manuscript – LMA; critical revision of the 
manuscript for important intellectual content – all authors. 
Financial support: No specific funding was received for the conduct of this review.  
Keywords: critical care, sedation, deep sedation, systematic review, patient outcome assessment, 
critical care outcomes 






Purpose: To determine the effect of depth of sedation on intensive care mortality, duration of 
mechanical ventilation, and other clinically important outcomes.  
Methods: We searched MEDLINE, Embase, CENTRAL, CINAHL, PsycINFO from 2000 - 2020. 
Randomised controlled trials and cohort studies that examined the effect of sedation depth were 
included. Two reviewers independently screened, selected articles, extracted data and appraised 
quality. Data on study design, population, setting, patient characteristics, study interventions, depth of 
sedation and relevant outcomes were extracted. Quality was assessed using Critical Appraisal Skills 
Programme tools.   
Results: We included data from 26 studies (n=7865 patients): 8 RCTs and 18 cohort studies. 
Heterogeneity of studies was substantial. There was no significant effect of lighter sedation on 
intensive care mortality. Lighter sedation did not affect duration of mechanical ventilation in RCTs 
(mean difference [MD]: -1.44 days [95% CI -3.79 to 0.91]) but did in cohort studies (MD: -1.54 days 
[95% CI -2.68 to -0.39]). No statistically significant benefit of lighter sedation was identified in 
RCTs. In cohort studies lighter sedation improved time to extubation, intensive care and hospital 
length of stay and Ventilator Associated Pneumonia. We found no significant effects for hospital 
mortality, delirium or adverse events. 
Conclusion: Evidence of benefit from lighter sedation is limited, with inconsistency between 
observational and randomised studies. Positive effects were mainly limited to low quality evidence 






KEY MESSAGES  
What is the key question? 
Does depth of sedation effect intensive care mortality and duration of mechanical ventilation, as well 
as secondary physiological, hospital mortality, resource use, adverse event and life impact outcomes? 
What is the bottom line? 
Evidence of the effect of sedation depth is limited, with inconsistency between observational and 
randomised studies. Positive effects from lighter sedation were mainly limited to low to very low 
quality evidence from observational studies. 
Why read on? 
Depth of sedation appears to have differential effect on various outcomes. We need to build on the 





Mechanically ventilated patients in intensive care receive sedation and analgesia to manage their 
discomfort. Although these medications are considered important for many patients, there is 
recognition that both the amount and type of sedation that patients receive are potentially related to 
patient outcomes (1). Various proposals and guidelines recommend alternative ways of administering 
sedation or using different sedative agents to improve outcomes from critical illness (1-3). Although 
interpretation of this literature is challenging due to inconsistent and problematic definitions, evidence 
suggests lighter sedation is probably beneficial (1). Despite this, recent reports show many ICU 
patients worldwide continue to be deeply sedated (4-6).  
In a recent review of outcomes associated with sedation depth in the first 48 hours of mechanical 
ventilation across the Emergency Department (ED) and Intensive Care Unit (ICU) lighter sedation 
was associated with reduced mortality, mechanical ventilation and ICU stay days (7). Given many 
critically ill patients remain heavily sedated for longer than 48 hours, it would be useful to know if 
this relationship between sedation depth and patient outcomes extends across patients’ entire ICU stay 
and relates to a range of patient outcomes or only the short term outcomes of mortality and duration of 
mechanical ventilation and ICU stay. The effect of lighter sedation on selected outcomes was also 
examined in the PADIS guidelines, however the included meta-analysis incorporated only studies 
where sedation depth was defined a priori (1), with inconsistent evidence identified. These reviews 
provide some insights into the evidence to guide sedation practice, but both reviews focused on 
specific subgroups of studies. We therefore considered a review of a wider range of relevant studies 
appropriate and important.  
Objective 
To systematically examine the effect of depth of sedation in ICU patients on patient outcomes that 
extend across the ICU stay and beyond. ICU mortality and duration of mechanical ventilation were 
co-primary outcomes selected because ICU mortality is patient-focused and duration of mechanical 
ventilation reflects sedation practice. Secondary outcomes from the five domains of the outcome 
taxonomy proposed by Dodd and colleagues (8) were selected and included hospital mortality, 
physiological outcomes (time to extubation, ventilator free days (Vfd) to day 28), resource use (ICU 
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and hospital length of stay), adverse events (incidence of delirium, self-extubation, reintubation and 
tracheostomy, ventilator associated pneumonia (VAP)) and life impact outcomes (memories, anxiety, 
depression and symptoms or diagnosis of PTSD); these latter outcomes mirror those identified as 
important to patients and family members in a research priority setting exercise (9). 
METHODS 
The protocol for this systematic review was registered on PROSPERO (CRD42018092554;  
www.crd.york.ac.uk/prospero/display_record.php?RecordID=92554). Additional detail is available in 
supplementary materials. 
Search strategy  
MEDLINE, Embase, Cochrane Register of Controlled Trials (CENTRAL), Cumulative Index to 
Nursing and Allied Health Literature (CINAHL) and PsycINFO were searched with the following 
strategy: (intensive care OR critical care OR critically ill) AND (sedat* OR midazolam OR propofol) 
AND (length of stay OR mortality OR outcome assessment OR physical function OR psychological 
OR cognitive OR memories). 
We searched for publications reporting randomized controlled, quasi-experimental and before-after 
trials, and cohort studies (prospective and retrospective) published in English between January 2000 
and February 2020.  
Types of participants 
We included studies in adult patients receiving invasive mechanical ventilation in ICU, including 
patients who commenced their ventilation in another location, e.g. ED, operating room. We excluded 
studies: (i) in patients receiving non-invasive ventilation and mechanically ventilated patients not 
admitted to ICU; (ii) where the intervention included different sedative agents. Studies testing the 
effect of different sedative agents were excluded because it is not possible to determine if any 
difference in outcome was due to effect of the different agent or different depth of sedation. We 
defined our exposure as deeper sedation at any time throughout the period of mechanical ventilation 
in the ICU. Our classification of depth of sedation as either ‘lighter’ or ‘deeper’ did not need to be 
(but could be) predefined by study authors, but was based on published information incorporating any 
objective measures of sedation depth including assessment using a validated sedation assessment 
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instrument, hourly or daily doses of sedatives. To clarify, studies that tested any intervention (e.g. 
goal or protocol directed sedation, no sedation), other than different sedative agents, were eligible for 
inclusion if one group of patients received lighter sedation than another group of patients in the study. 
Studies were not excluded on the basis of which sedative agent they used, and no attempt was made to 
control analgesic use, although it is recognised that many have a secondary sedative effect. Only the 
RASS and Riker Sedation-Agitation Scale (SAS) were accepted as validated instruments (10).  
Study selection  
Titles and abstracts were screened independently by two researchers, with full text of included studies 
reviewed by two authors to assess eligibility. Studies where separation of depth into ‘lighter’ and 
‘deeper’ sedation could not be identified were excluded.  Studies including >2 groups based on 
sedation depth were not included in the meta-analysis but were retained in the additional analyses. 
Sedation was defined as the use of pharmacological agents that have the primary purpose of calming 
or inducing sleep, and alternative agents such as analgesics were not included despite acknowledging 
that secondary effects of sedation are often present. We did not include different outcomes from the 
same patient cohort, reported in multiple papers, twice in any analysis but this relationship was noted.  
Data Extraction  
Two authors extracted data on study design, population and setting, patient characteristics, study 
interventions, measure of depth of sedation (methodology and results) and relevant outcomes. 
Assessment of bias 
The domains of bias for RCTs and cohort studies were assessed  consistent with current guidance 
(11,12). Relevant confounding factors were not identified a priori, but were based on the study 
method and cohort and included demographic, clinical, and treatment variables with the potential to 
influence relevant outcomes. No studies were excluded on the basis of quality assessment.  
Data Analysis  
Two authors extracted data on study design, population and setting, patient characteristics, study 
interventions, measure of depth of sedation (methodology and results) and relevant outcomes. All 
studies that contained data suitable for inclusion in at least one meta-analysis were included in the 
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quantitative analysis. Continuous data were analysed as means and standard deviations. Where the 
median and inter-quartile range was reported, these were converted to mean and standard deviation 
using a standard method (13). Dichotomous data were analysed as risks and relative risks. Random 
effects meta-analyses were undertaken with the meta package (14) in R (15). This allowed for both 
within and between studies variance to be calculated, the latter being reflected in a statistical test of 
heterogeneity. Cohort studies and RCTs were analysed separately based on an a priori decision. The 
quality of evidence was rated using Grades of Recommendation, Assessment, Development and 
Evaluation (GRADE) (16). For outcomes where significant methodological differences occurred (e.g. 
different instruments or time points) results were combined descriptively.  
Sensitivity analysis  
Categorisation of patients into ‘lighter’ and ‘deeper’ sedation groups could be based on either a 
difference in RASS or SAS scores, a difference in average dose of sedation over time (hourly/daily) 
or a combination of both. Due to the potential differential effect of sedation amounts on patients’ 
sedation levels, a post hoc decision was made to repeat meta-analyses incorporating only those studies 
where categorisation was based on RASS or SAS scores alone or in combination with sedation dose, 
i.e. to exclude studies where categorisation was based solely on sedation dose. Similarly, a post hoc 
analysis of cohort studies to examine the influence of the temporal nature of the design (i.e. 
prospective or retrospective) was conducted.  
RESULTS  
After removal of duplicates, 3390 articles were identified (Figure 1), with full text of 116 articles 
assessed. Ninety were excluded: 69 met exclusion criteria; and 21 because, although patients were in 
groups, levels of sedation did not differ between the groups.  
Twenty-six articles reporting the results of 23 studies incorporating 8575 patients remained for 
descriptive synthesis with 17 articles (7027 patients) included in a meta-analysis for at least one 
outcome (17-33). The included papers reported results prospective (n=16; n=5534) and retrospective 
(n=2; n=2028) cohort studies and randomised controlled trials (n=8; n=1534) published between 2001 
and 2020 conducted across Asia (n=2), Australia and New Zealand (n=3), Europe (n=10), Middle-east 
(n=1) and North (n=7) and South America (n=4) (Table S1). Depth of sedation was measured either 
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using sedation assessment instruments or average doses of sedatives or a combination of both (Table 
1, Table S2). The level of sedation that constituted ‘lighter’ or ‘deeper’ sedation was inconsistent 
across studies.  
Risk of bias was highly variable in the cohort studies. In the RCTs risk of bias was more consistent, 
with lack of blinding being the main source of bias. Blinding of participants and personnel was not 
possible and blinding of outcome assessors was rare (Figure S1, Table S3). There was infrequent 
incorporation of relevant confounding factors into analysis in cohort studies (Figure S2, Table S4).  
Included studies addressed both our primary outcomes, and secondary outcomes within the five 
domains of mortality, physiological outcomes, resource use, adverse events and life impact outcomes 
(8) (Table S5), with most outcomes assessed in meta-analyses (Table 2). Outcomes within the life 
impact domain could not be pooled, but a descriptive synthesis of results related to memory and 
psychological function is provided (Table 3). Studies not included in the meta-analyses are 
synthesised under Additional Analyses.  
Primary Outcomes 
ICU Mortality: When comparing lighter versus deeper sedation we found no difference in ICU 
mortality in either RCTs or cohort studies (Table 2, Figure 2).  
Duration of mechanical ventilation: We found no difference in duration of mechanical ventilation in 
the RCTs comparing lighter versus deeper sedation, but identified reduced duration of mechanical 
ventilation with lighter sedation in cohort studies (MD -1.54 days [95% CI:-2.68 to -0.39], I2=87%, 8 
studies, 3304 participants) (Table 2, Figure 2). 
Secondary Outcomes 
Hospital Mortality: Pooled data from 5 RCTs and 5 cohort studies showed no difference between 
lighter and deeper sedation on hospital mortality (Table 2, Figure S3).  
Physiological outcomes: Pooled data from 4 RCTs and 2 cohort studies showed no difference 
between lighter and deeper sedation on 28-day Vfd (Table 2, Figure S4). There was no difference in 
time to extubation in a single RCT, but cohort studies reported reduced duration with lighter sedation 
(MD -3.77 days [95% CI:-5.49 to -2.06], I2=98%, 2 studies, 2132 participants). Pooled data from 4 
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RCTs and 4 cohort studies showed no difference between lighter and deeper sedation on incidence of 
delirium (Table 2, Figure S4).  
Resource Use: Pooled data from 6 RCTs showed no difference between lighter and deeper sedation 
on ICU LOS or hospital LOS, but a significant reduction favouring lighter sedation was identified in 
ICU and hospital LOS in cohort studies (8 and 6 studies respectively Table 2, Figure S5). Lighter 
sedation had no effect on frequency of tracheostomy (4 RCTs, 2 cohort studies; Table 2).  
Adverse Events: We found no difference between lighter and deeper sedation on self-extubation (2 
RCTs, 3 cohort studies) or reintubation (5 RCTs, 2 cohort studies) (Table 2, Figure S6). Lighter 
sedation had no effect on risk of VAP in 1 RCT, although data from 2 cohort studies showed a 
reduced risk with lighter sedation (RR 0.56 [95% CI:0.33 to 0.96], I2=51%, 1906 participants) (Table 
2, Figure S6).  
Sensitivity analyses  
Meta-analyses, incorporating only those studies where RASS or SAS data were available to categorise 
patients as lighter or deeper sedation, were repeated on outcomes where studies existed. Results were 
largely similar, although fewer significant differences were identified (Table S6). 
Meta-analyses examining the influence of the temporal nature of the design in cohort studies, i.e. 
prospective or retrospective, were conducted. Results were largely similar to the overall results, 
although analysis of only the prospective studies substantially reduced the heterogeneity when 
examining ICU and hospital mortality and hospital length of stay but had no effect on heterogeneity in 
relation to other outcomes (Table S7).  
Additional analyses 
Nine studies met the inclusion criteria, but were excluded from all meta-analyses for reasons detailed 
in the Methods (34-42). The main reasons were single group cohort studies with multivariable 
regression analysis (35,39) or more than 2 groups of patients not able to be combined based on 
sedation depth (34,40), as well as variable time points and methods for outcome measurement. In 
addition, some studies (where the primary outcome has been incorporated in meta-analyses above) 
incorporated life impact outcomes as secondary measures, however differences in methods of 
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outcome assessment precluded a meta-analysis of life impact outcomes. A descriptive synthesis is 
provided here. 
Mortality, physiological outcomes and adverse events: A positive relationship between deep sedation 
and increased mortality (35,39) and increased duration of MV (39,40) was reported in cohort studies, 
but depth of sedation was not associated with MV duration across different stages of implementation 
of a sedation protocol and education intervention (34). A relationship between deeper sedation and 
both delirium (39) and VAP (34) was identified.  
Life Impact: Outcomes reflecting the impact of sedation depth on a person’s life focused only on 
memories and psychological health measured in 10 studies using a variety of instruments at different 
times (Table 3). There was some evidence of a relationship between sedation depth and presence or 
type of memories that patients reported. In a cohort study of 128 Brazilian patients, those who 
received any sedation reported less real memories (21[24%] vs 29 [69%]), more illusionary memories 
(7[8%] vs 0) and more amnesia (16[19%] vs 4[10%]) than patients who received no sedation (40). In 
a cohort study of 313 Swedish patients increased time deeply sedated was associated with having no 
recall of ICU (odds ratio [OR]:1.60, 95% CI:1.35–1.91) (37). In further analysis of the same cohort, 
patients who spent more time awake were more likely to remember the endotracheal tube (OR:1.45, 
95% CI:1.29–1.62) and be bothered by memories of stressful ICU experiences (OR:1.37, 95% 
CI:1.13–1.67), but sedation depth was not associated with nightmares during recovery (38). In 
contrast, in 289 patients in Canada and USA, patients with no recall of ICU received lower daily 
doses of midazolam (26.9 [SD 63.7] vs 82.5 [SD 314] mg), but delusional memories were not 
associated with higher sedative doses (OR:1.18, 95% CI:0.37–3.81) (41). No difference in frequency 
or type of memories was reported in 2 studies (27,36) or in studies exploring the relationship between 
psychological distress and sedation depth (18,24,30,40,42).  
DISCUSSION  
In this systematic review of data from 26 studies incorporating just under 8000 adult patients there 
was inconsistent and inadequate evidence of the relationship between sedation depth and patient 
outcomes. Moderate level evidence from RCTs was identified in relation to the primary outcomes of 
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ICU mortality and duration of mechanical ventilation, as well as secondary outcomes including 
hospital mortality, time to extubation, ventilator free days, ICU LOS, incidence of delirium and 
tracheostomies, however no benefit of lighter sedation was identified in any of these outcomes. 
Outcomes where benefit of lighter sedation was shown in cohort studies included duration of 
mechanical ventilation, time to extubation, ICU and hospital length of stay and VAP; the evidence 
was assessed as very low level for all these outcomes. Reasons for low levels of evidence were multi-
factorial but included inconsistency and imprecision, frequently with very high levels of 
heterogeneity, likely occurring as a result of differences in the primary aim and design of included 
studies as well as variation in interventions used to achieve lighter sedation. The multi-dimensional 
nature of factors that influence each of the outcomes also likely influences the inconsistency in 
results. High levels of heterogeneity potentially occurred as a result of the different designs (RCTs as 
well as prospective and retrospective cohort studies), the intent of the project (e.g. primarily as a 
quality improvement project) and the level of sedation and intervention fidelity achieved. The 
heterogeneity shown in this review highlights the issue of sedation being a complex healthcare 
invention influenced by multiple factors including agent chose, patient characteristics, protocols and 
practices, contextual issues within ICUs and individual clinician values and beliefs. These issues 
increase the relevance of the possible uncertainty highlighted in our review.  
There was little evidence of effect of sedation depth on life impact outcomes. There was no evidence 
that anxiety, depression or symptoms of post-traumatic stress were related to sedation depth 
(18,24,30,40,42). There was, however, inconsistent evidence of whether, and how, sedation depth 
might influence the presence and type of memories (18,27,36-38,40,41). The role of memories after 
critical illness, and the relationship with psychological health, is inconsistent, with some suggestion 
that intrusive, persecutory or delusional memories may be more harmful than real memories (43), 
with the possibility that more frightening memories might be associated with greater psychological 
trauma (44). No evidence of a relationship between sedation depth and delirium was identified in this 
review, however any potential relationship between sedation, delirium and memories requires further 
investigation (43).  
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Few of the included studies identified an a priori aim related to sedation depth. Instead, many studies 
examined the effect of interventions to improve sedation practice, or explored the relationship 
between sedation and outcomes. Labelling of groups as ‘deeper’ and ‘lighter’ sedation in this review 
may not be appropriate given that ‘deeper’ sedation in one study could be similar to ‘lighter’ sedation 
in another study or setting. For example, RASS -3 indicated moderate sedation in one study (40) and 
deep sedation in others (17,20), while one pre-post study achieved ‘lighter’ sedation with a median 
first RASS score of -4 post-intervention (17). No studies targeted RASS 0 to -1 (alert and calm to 
drowsy), with the exception of work from Scandinavia examining ‘no sedation’ (25,29,42). The 
diversity of clinical practice strategies to achieve lighter sedation also presented challenges. We aimed 
to summarise whether strategies, whatever their design or content, that targeted deeper sedation 
avoidance were effective in changing outcomes relative to the comparator.  
Recently, a Peruvian multi-centre observational cohort study examining the relationship between 
benzodiazepine dose and mortality was published (45). In this study benzodiazepine dose was 
associated with a higher risk of mortality and a significant decrease in Vfd, although it should be 
noted that 98% of participants were deeply sedated at some point during the study and depth of 
sedation was assessed using either the Glasgow Coma Scale, Ramsay Sedation Scale or RASS. The 
primary results of the SPICE-III study comparing dexmedetomidine to usual sedation are also 
published (6). SPICE-III compared different sedatives and was therefore ineligible for this review. 
However, it is worth noting that although the dexmedetomidine group had a slightly higher proportion 
of patients with lighter RASS scores (56.6% vs 51.8%), no difference in outcomes was observed. In 
two French studies also not meeting our inclusion criteria, one multicentre study found no difference 
in Vfd or mortality with the introduction of an oversedation prevention strategy (46), while a single 
centre study found reduced duration of mechanical ventilation by stopping sedation immediately after 
ICU admission (47). The most recent relevant study published was the Danish NONSEDA study 
where a strategy of no sedation was compared to light sedation (25). In this high quality RCT with 
clear separation in sedation levels, a non-significant trend towards higher mortality in the non-sedated 
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group was identified, emphasising the need for a strong body of evidence to illuminate the effect of 
sedation depth on a range of patient outcomes.  
The reasons for reporting the effects of sedation depth on clinical outcomes from cohort studies 
alongside those from RCTs deserves attention. Changing sedation practice frequently requires an 
integrated or bundled approach to sedation assessment and management to achieve cultural change of 
clinician behaviour (2,48). Cohort (before and after) studies are more amenable to achieve practice 
change than randomised studies. Once a shift in clinicians’ sedation management behaviour has been 
learned, it can be difficult to apply earlier (usual care) practices when patients are randomised. The 
RCTs in this review all randomised at the patient level. So, although cohort studies provide lower 
quality evidence than RCTs, in the area of sedation practice they have provided a pragmatic method 
for studies designed to modify sedation depth. To improve the quality of evidence, we recommend 
cluster randomised trials to address the weakness of intervention contamination in patient level 
randomisation and improve the quality of evidence. We have also provided ratings of evidence using 
the GRADE criteria (16), although we note the limitations of this system in that it is based on 
subjective judgements and does not take into account the benefits of various study methodologies as 
outlined above.  
There have been multiple calls in clinical guidelines and opinion papers for lighter sedation in ICU 
patients (1,2); these calls have been based on sub-sets of the available evidence (7) or individual 
studies (e.g. (28,49).  In response to these calls, multiple strategies have been proposed to achieve 
lighter sedation including protocols (50), expert staffing patterns (51) and daily interruption of 
sedation (52). To date, systematic reviews have not identified consistently useful strategies (53,54), 
although reviews are ongoing (55).  
This review represents the most comprehensive description of the current evidence related to sedation 
depth and patient outcomes. Despite the use of liberal inclusion criteria, and a wide range of outcomes 
examined, the certainty of evidence remains low and inconsistent. Additionally, the findings are 
limited by the variable nature of how ‘lighter’ and ‘deeper’ sedation were determined in the studies, 
the lack of control of analgesic agents and the frequent lack of determining this differentiation a priori 
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or indeed stating it as an aim. In some studies, the only measure of sedation depth was average dose of 
sedation, which may not reflect sedative effect on the individual patient. Ideally validated sedation 
scores such as RASS or SAS should be used to indicate the actual depth to which a patient is sedated. 
Yet, despite a sensitivity analysis of studies where the difference in sedation depth was based on 
RASS or SAS, the lack of consistency in effect on patient outcomes remained. The review only 
included studies that used sedation assessment scales validated for use in the ICU environment in 
international practice guidelines (10), and thus may have had the effect of biasing the meta-analysis. 
The review was also limited by including English language publications and published data only. The 
preponderance of cohort studies including those using two groups of patients before and after a 
behaviour change intervention, and the implicit limitations of them, represents a limitation of this 
body of evidence. There was also no examination of the effect of sedation depth on related activities 
such as early mobilisation or on infrequently measured adverse events such as thromboembolic 
events.  
Based on the low certainty of evidence, there is an urgent need for systematic evaluation of the effect 
of sedation depth on patient-centred outcomes to provide direction for sedation management. Studies 
addressing this question should use a randomised controlled trial design, ideally with randomisation at 
cluster level to achieve cultural change in clinician behaviour. Studies should incorporate a priori 
identification of target ‘light’ sedation levels, based on individual patient need, and the effect on a 
range of patient-centred outcomes (56,57) should be assessed.  
Despite inconsistency in results, all clinical benefits identified in this review were related to lighter 
sedation, and importantly this review did not identify any harm related to lighter sedation. In this 
context, strategies to embed lighter levels of patient sedation in critical care are warranted. The 
challenging and multi-dimensional nature of sedation practice has been identified (58), and additional 
evidence-based strategies are urgently needed to optimise sedation and related areas of care such as 




Despite a considerable body of evidence discussing the relationship between sedation depth and 
various outcomes, we identified low to very low quality evidence suggesting that lighter sedation may 
be beneficial in some patient outcomes. The inconsistency of this evidence is exacerbated by the 
variable risk of bias in included studies, the different evidence of impact between RCTs and cohort 
studies, the inconsistent evidence of benefit across different outcomes and the inconsistent methods 
used, preventing combining data in meta-analyses. Future studies using rigorous controlled trial 
designs measuring patient centred outcomes, with randomisation occurring at the cluster level, are 
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Table 1 Criteria used in studies to separate ‘deeper’ vs ‘lighter’ sedation1  




Patients had >85% RASS scores ≤-3 
First RASS -5[-5 to -4]  
Time to reach first RASS>-3:79[52-141]hrs 
First RASS: -4[-5 to -1], p< 0.001 





Midazolam: 0.03[0.01-0.06]  mg/kg/hr  
Fentanyl: 0.6[0.1-1.4] mcg/kg/hr 
Proportion: SAS 1–2:55%; SAS 3–4:37% 
Midazolam: 0.01[0-0.03] mg/kg/hr, p<0.001  
Fentanyl: 1.5[0.8-2.4] mcg/kg/hr, p<0.001  
Proportion: SAS 1–2:44%; SAS 3–4:49%, p=0.001 
Burry 2015 
 
Midazolam: 97.0±200.8 mg/patient/day  
Fentanyl: 1.9±3.5 mg/patient/day  
Midazolam: 64.7±245.8 mg/patient/day, p<0.0001 
Fentanyl: 1.1±2.0 mg/patient/day, p<0.0001 
Dale 2014 
 
Hrly benzodiazepine dose: 0.23±0.018 mg 
Total benzodiazepine dose: 49.2±156.5 mg 
24 hr weighted av. RASS: -1.30±0.026 
Hrly benzodiazepine dose: 0.15±0.011 mg, p<0.01 
Total benzodiazepine dose: 17.2±53.6, p<0.01 
24 hr weighted av. RASS: -0.99±0.023, p <0.01 
Faust 2016 
 
RASS (median): -2.57[-3.23 to -1.40] 
% RASS scores -3 to -5 in first 24 hrs: 
46.8±46.9% 
RASS (median): -1.25[-2.3 to -0.40], p=0.001 




Classed as ‘minimally arousable’ based on 
Sedation Intensity Score  




RASS scores – weekdays: median -4 
RASS scores – weekends: median – 5 
RASS – weekdays: increased by 0.88, p <0.0001 
RASS – weekends: increased by 1.20, p <0.0001 
Mehta 
20122 
Midazolam: 102±326 mg/pt/day  
Fentanyl: 1780±4135 µg/pt/day  
Midazolam: 102±326 mg/pt/day, p=0.04  
Fentanyl: 1070±2066 µg/pt/day, p<0.001 
Nassar 
Junior 2014 
SAS scores: 3.2(2.6-3.7) 
Midazolam: 45(0,201) mg,  
Fentanyl: 1500(520-4215) mg 
SAS scores: 3.6(3.4-4.0), p=0.035 
Midazolam: 0(0.0-0.05) mg, p<0.001  
Fentanyl: 300(100-1520) mg, p=0.004 
Olsen 2020 Midazolam mg/kg/hr (day 2-28):0.000187 (0-
0.003410) 
Propofol mg/kg/hr (day 1-2):0.84 (0.29-1.2); 
(day 3-28):0.0064 (0-0.034) 
Mean RASS: Day 1: -2.3; Day 7: -1.8 
Midazolam mg/kg/hr (day 2-28):0(0-0.000005); NS 
Propofol mg/kg/hr (day 1-2): 0.22(0-0.054); Diff: -
0.62 (-0.72; -0.53); (day 3-28): 0(0-0.013); Diff: -
0.0063(-0.874; -0.0037) 
Mean RASS: Day 1: -1.3; Day 7: -0.8 
Quenot 
2007 
Midazolam: 92±59 mg/pt/day 
Propofol: 2900±1400 mg /pt/day 
Midazolam: 44±31 mg/pt/day, p=0.001  
Propofol: 1840±750 mg/pt/day, p=0.01 
Ren 2017 Sufentanil: 0.030±0.007 mg/kg/hr 
Midazolam: 0.029±0.007 mg/kg/hr 
Sufentanil: 0.018±0.009 mg/kg/hr, p<0.0001 
Midazolam: 0.017±0.009 mg/kg/hr, p<0.0001 
Samuelson 
2008  
Target MAAS: 1 – 2 
Actual MAAS: median 1.25(1.0)  
Target MAAS: 3 – 4 
Actual MAAS: median 3.0(0.0) 




Dexmedetomidine: 20.58(20.58-20.58) µg 
Midazolam: 0.3(0.23-0.76) mg 
Propofol: 33.55(13.54-77.07) mg 
RASS assessments -2 to +1: 38% 
Dexmedetomidine:36.55(16.38-13.23)µg, p<0.0001 
Midazolam: 0.06(0.02-1) mg, p=0.036 
Propofol: 9.89(2.41-22.51) mg, p=0.046 
RASS assessments -2 to +1: 66%, p=0.01 
Shehabi 
2012 
RASS -3 to -5 at 48 hours  
 
RASS lighter than -3 to -5 at 48 hours 
 
Strøm 2011 Propofol: 1.40(0.52-2.04) mg/kg/hr 
Midazolam: 0.01(0-0.04) mg/kg/hr 
Propofol: 0(0-1.26) mg/kg/hr, p=0.013 
Midazolam: 0(0-0) mg/kg/hr, p=0.003 
Strøm  
2010 
Propofol: 0.77(0.15-1.65) mg/kg/hr 
Midazolam: 0.003(0-0.024) mg/kg/hr 
Propofol: 0(0-0.52) mg/kg/hr, p=0.0001 




Target Ramsay sedation score 3 – 4 
Daily median Ramsay range: 3(2-4.5) to 4(3-5)  
Daily Midazolam range: 24.2±45.1 to 
95.3±124.5 mg 
Target Ramsay sedation score 1 – 2  
Daily median Ramsay range: 1(1-2) to 3(1-3)  
Daily Midazolam range: 3.0±5.0 to 11.7±23.2 mg 
1. It was not possible to create 2 categories of ‘deeper’ or ‘lighter’ sedation in 7 studies (34-39)  
2. ‘deeper’ sedation group was the intervention (Daily Interruption of Sedation) group  




Table 2: Summary of findings 











[mean (range) of 
mean value 
reported in each 
study]1 
Effect Estimate & 
95% CI (Risk ratio 
for events2; Mean 
Difference for 
duration3) 






RCT  4 (725) 28.8 (14.1 – 40.0)  0.82 [0.58 to 1.17]2 30%  Moderate  





RCT  2 (165) 6.6 (5.5 – 7.7)  -1.44 [-3.79 to 0.91]3  20% Moderate  
 Cohort  8 (3304) 7.1 (1.2 – 10.7)  -1.54[-2.68 to -0.39]3 87% Very low  
Secondary outcomes 
Mortality        
Hospital mortality 
(%) 
RCT  5 (762) 29.8 (12.5 – 46.6)  0.93 [0.75 to 1.15]2 0% Moderate  




RCT  1 (423) 8.0 (8.0 – 8.0) -0.67 [-1.95 to 0.61]3 0% Moderate  
 Cohort  2 (2132) 5.6 (3.7 – 7.4)  -3.77[-5.49 to -2.06]3 98% Very low  
Ventilator free 
days to day 28 
(days) 
RCT  4 (910) 15.3 (9.6 – 20.1)  2.62 [-0.09 to 5.34]3 31% Moderate 
 Cohort  2 (431) 17.0 (10.3 – 23.6)  0.65 [-0.65 to 1.95]* 0% Low  
Delirium (%) RCT  4 (556) 30.1 (0 – 52.8) 1.04 [0.88 to 1.23]2 0%  Moderate  
 Cohort  4 (3953) 37.2 (10.7 – 55.3)  1.01 [0.63 to 1.62]2  95%  Very low  
Resource Use 
ICU length of 
stay (days) 
RCT  6 (1462) 14.8 (6.3 – 28.0)  0.28 [-1.46 to 2.02]3  32% Moderate  
 Cohort  8 (4537) 11.9 (3.7 – 23.7)  -4.30[-7.39 to -1.21]3 97% Very low  
Hospital length of 
stay (days) 
RCT  5 (762) 27.5 (16.6 – 58.6) -0.69 [-6.96 to 5.58]3  80% Very low 
 Cohort  6 (4917) 19.9 (12.3 – 30.7) -4.21[-7.22 to -1.19]3  88% Very low  
Tracheostomy 
(%) 
RCT  4 (725) 15.4 (3.3 – 29.3) 1.07 [0.81 to 1.43]2  0%  Moderate  




RCT 2 (189) 3.2 (3.1 – 3.3)  1.31 [0.30 to 5.82]2  0%  Moderate  
 Cohort  3 (854) 6.4 (3.1 – 9.0)  1.32 [0.84 to 2.09]2  0%  Low  
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Abbreviations: ICU: Intensive Care Unit, RCT: Randomized Control Trial, VAP: Ventilator-Associated 
Pneumonia 
Grade Assessment: RCTs started at high quality; Cohort studies started at low quality (due to risk of bias); 
Reasons for downgrade included risk of bias (RCTs), imprecision, inconsistency, indirectness.  
Notes: 1 – Values for clinical parameters in study populations in deep sedation groups for included studies 
[mean (range) of mean deep sedation group value reported in each study]; 2 – Risk ratio for events; 3 – Mean 
Difference for duration. 
Re-intubation (%) RCT  5 (1348) 7.2 (1.6 – 13.3)  1.45 [0.78 to 2.71]2  30%  Low  
 Cohort  2 (362) 4.2 (1.5 – 6.9)  1.07 [0.43 to 2.65]2  0%  Very low  
VAP (%) RCT  1 (113) 12.1 (12.1 – 12.1)  0.90 [0.32 to 2.52]2  0% Low  
 Cohort  2 (1906) 10.8 (6.5 – 15.0)  0.56 [0.33 to 0.96]2 51% Very low  
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Table 3. Life impact outcomes  
Study  Time point  Outcome measured  Results  
Bugedo 
2013 
1 year post 
discharge 
Screening for memories 
via telephone interview. 
Post-Traumatic Stress 
Syndrome – 10 (PTSS-
10) Scale 
No difference in incidence of nightmares (n= 
22[55%] vs 15[43%], p=0.294), severe anxiety 
or panic (n= 16[40%] vs 12[34%], p=0.610) or 
pain (n= 12[30%] vs 13[37%], p=0.513, feelings 
of suffocation or PTSS-10 (28[19-3(sic)] vs 
26[17-38], p=0.840) questionnaire scores 





28 days post 
ICU 
discharge  
ICU Memory Tool Patients who reported ‘not remembering the 
ICU’ had less sedation (average daily 
midazolam dose 26.9 [SD 63.7] vs 82.5 [SD 
314] mg), but no difference in SAS scores (3.34 
[SD 0.70] vs 3.27 [0.65]). In a multivariate 
model, total midazolam (OR 1.182, 95% CI 0.37 
– 3.81) and fentanyl (OR 2.27, 95% CI 0.64 – 
8.14) exposure above the mean (deeper sedation) 












No significant difference in recall of factual (A 
(No morphine/minimal sedatives): n=16[36%]; 
B (Morphine only): 29[34%]; C (Morphine and 
sedatives): 4[18%]), sensation (A: n=4[9%]; B: 
13[15%]; C: 3[14%]) or emotional (A: n=4[9%]; 
B: 6[7%]; C: 4[18%]) memories of ICU between 
the groups. 
Costa 2014  Approximate
ly 3 days 
post ICU 
discharge 
Locally adapted ICU 
Memory Tool  
Not specified how 
anxiety, depression or 
PTSD were measured  
No difference in the incidence of anxiety, 
depression or PTSD across mild-moderate, deep 
or not sedation groups. Patients who received 
any level of sedation reported less real memories 
(21[24%] vs 29 [69%]), more real and illusory 
memories (42[49%] vs 9[21%]), more illusory 
memories (7[8%] vs 0) and more amnesia 
(16[19%] vs 4[10%]) than patients who received 






Impact of Events Scale 
(IES) 
No difference in the level of psychological stress 
on the IES (22[8-31] vs 16[4-34], p=0.750) 
between intermittent sedation or daily 
interruption of sedation groups. 
Samuelson 
2006 
3 – 5 days 
post ICU 
discharge  
ICU Memory Tool  Deep sedation was associated with amnesia (OR 
1.60, 95% CI 1.35 – 1.91) and delusional 




3 – 5 days 
post ICU 
discharge  
ICU Memory Tool  
Locally adapted ICU 
Stressful Experiences 
Questionnaire  
Patients with memory of ETT had higher 
proportion of MAAS 3 (awake) than those with 
no memory (0.56[0.42] vs 0.18[0.42], p<0.0001) 
- this relationship was confirmed on multivariate 
analysis (OR 1.45, 95% CI 1.29 – 1.62). 
Similarly, patients with a higher proportion of 
MAAS 3 were more likely to be bothered by 
memories of stressful experiences of ICU (OR 
1.37, 95% CI 1.13 – 1.67).   
Samuelson 
2008  
3 – 5 days 
post ICU 
ICU Memory Tool 
Locally adapted ICU 
No difference in memories of ICU (n=15[88%] 




2 months  
Stressful Experiences 
Questionnaire 
Impact of Events Scale - 
Revised 
memories in ICU (n=1[6%] vs 6[33%], p=0.09), 
or memories of pain (n=4[23%] vs 9[50%], 
p=0.20) between the groups. 
Strom 2011  2 years post 
randomisatio
n   
ICU Memory Tool  
SF-36, Beck Depression 
Index (BDI), Impact of 
Events Scale (IES), 
State Anxiety Inventory, 
PTSD Symptoms 
(PTSS) - 10 
No difference in psychological problems post-
discharge (n=2[15%] vs 6[46%], p=0.20), PTSS-
10 score >35 (n=1[8%] vs 0[0%], p=0.14) or any 
of the other psychological health outcomes 




and 4 weeks 
post ICU 
discharge  
PTSD Checklist (PCL)  
Impact of Events Scale 
– Revised (IES-R)  
Hospital Anxiety and 
Depression Scale 
(HADS) 
No difference in PTSD questionnaire score 
(discharge: 57±30 vs 52±33, p=0.39; 4 wk 
follow-up: 56±29 vs 46±29, p=0.07), PTSD 
symptom clusters, anxiety or depression 
(discharge: 6.5±4.7 vs 5.3±3.4, p=0.13; 4 wk 
follow-up: 3.1±3.7 vs 3.4±3.7, p=0.72) scores or 
cases at either discharge or 4 week follow-up 



































Additional records identified 
through other sources 
(n=22) 






Full-text articles assessed for 
eligibility 
(n=116) 
Full-text articles excluded (n=90). 
Reasons: 
-Abstract (no further data or data 
included as different publication) n= 28 
-Insufficient data to assess ‘depth of 
sedation’ n=29 
-Systematic review or meta-analysis 
(reference list scanned) n=5 
-Outcomes not of relevance n=1 
-Wrong study cohort/intervention n=2 
-Other excluded publication type 
(letter/editorial) n=4 




Studies included in qualitative 
synthesis (n=26) 
Studies included in the 






Figure 2: Forest plots for primary outcome: a) ICU mortality; b) Duration of mechanical ventilation 
Note: data converted from median/IRQ to mean/SD12 for duration of MV in the following studies: 
Bugedo et al 2013; Dale et al 2014; Guttormson et al 2011; Quenot et al 2007; Sen et al 2017. 
 
 
 
